Colin Vale, MD
Myelodysplastic Syndromes (MDS) is a group of diseases that have a variety of different treatments and outcomes. In this episode, we speak to Dr. Colin Vale of Emory University in Atlanta, GA, about the treatments for MDS, the potential for transforming into acute myeloid leukemia (AML), and new strategies to give patients the quality of care that they deserve.
DOWNLOAD TRANSCRIPT
CLICK HERE to participate in our episode survey.
Mentioned on this episode:
Myelodysplastic Syndromes (MDS)IMerge Phase 3 Study (Imetelstat)Classification SystemsGermline Predisposition ArticlePatient-Doctor Perspectives: Hereditary Myelodysplastic Syndromes (MDS) | The Bloodline with LLSInternational Prognostic Scoring SystemAllogeneic Stem Cell TransplantationAdditional LLS Support Resources:
Information Specialists Financial supportFree telephone/web patient programs Free booklets Clinical Trial Support CenterYoung Adult ResourcesCaregiver support Caregiver WorkbookSurvivorship WorkbookOnline chats LLS Community Support groups Patti Robinson Kaufmann First Connection Program Free Nutrition ConsultationsSupport for this episode provided by: Taiho Oncology, Inc.
The post Improving Quality of Care for Myelodysplastic Syndromes (MDS) first appeared on The Bloodline With Blood Cancer United Podcast.